Chicago · Independent Healthcare AI Publication
A clinician's read on healthcare AI.
One briefing a week. Free. No vendor pitch.
Briefing No. 24 · Medical Affairs
27% of MSLs now use AI to prep for KOL meetings and only 33% of their companies have a policy. The function built to catch fabricated citations is adopting AI that writes them.
The Joint Commission started certifying hospitals for responsible AI in June 2026. The standard most will fail is the one that treats a clinical model as a perishable asset, not a one-time install.
No. 22 · Clinical AIThe largest objective study of ambient AI scribes clocked the gain at one minute per note. Systems that bought it as a productivity play will fail the CFO's test.
No. 21 · TelepharmacyCentral fill runs error rates below one in a million, yet telepharmacy can't scale past one pharmacist's verify click. The bottleneck is the law, not the tech.
Where AI is actually changing pharmacy, clinical operations, and medical affairs, plus the regulation moving underneath it.
TheraIntel is shorthand for therapeutic intelligence: clinical judgment brought to the AI reshaping pharmacy and care. It is an independent publication covering AI across pharmacy, telepharmacy, clinical operations, and medical affairs, written by Shan Siddique, PharmD, a practicing clinical pharmacist with over a decade of frontline healthcare operations experience.
The healthcare AI conversation is loud, and most of it is written by people who have never verified an order, run a pharmacist schedule, or briefed a clinician on the evidence. This is the operator's read: what the technology actually does, what the regulation actually says, and what it means for the people doing the work.
TheraIntel is an independent publication. The analysis here is editorial, written on personal time, and the views expressed are the author's own. They do not represent any employer.
More about TheraIntel →A clinician's analysis of the AI moves reshaping pharmacy, clinical operations, and medical affairs, plus the regulation moving underneath them. Built for operators, not the hype cycle.
Join the list and get the briefing in your inbox. No spam, unsubscribe anytime.
By subscribing you agree to receive email updates from TheraIntel. We never sell or share your address.
